Heart study tests safer stents and lower drug doses for ACS patients

NCT ID NCT02193971

First seen May 05, 2026 · Last updated May 06, 2026 · Updated 1 time

Summary

This study looked at over 3,400 people with acute coronary syndrome (a serious heart condition) who needed a stent to open blocked arteries. Researchers compared two types of stents (biostable vs. biodegradable polymer) and two doses of the blood thinner prasugrel (5 mg vs. 10 mg) to see which combination was safer and worked best. The goal was to find ways to reduce heart attacks, strokes, and bleeding risks while still effectively managing the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Seoul National University Hospital

    Seoul, 110-744, South Korea

Conditions

Explore the condition pages connected to this study.